Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Nebraska hearing on LB512 spotlights medication‑abortion safety, Bellevue inspection concerns
Summary
Lawmakers heard hours of pro and con testimony on LB512, a bill that would require in‑person screening and follow‑up for medication abortions and new reporting of complications after state inspectors flagged problems at a Bellevue clinic.
At a Health and Human Services Committee public hearing, legislators heard extended testimony for and against LB512, a bill that would require providers who prescribe abortion‑inducing drugs to confirm pregnancy and screen for ectopic pregnancy, offer a 3–14 day in‑person follow‑up, and report a defined set of adverse events to the Department of Health and Human Services.
The introducer, Senator Rick Holcroft, Legislative District 36, told the committee LB512 is a “first step towards establishing a basic minimum state standard of care.” He cited a 2023 facility inspection in Bellevue and said the bill responds to cases in which abortion drugs were dispensed without proper licensing and follow‑up. “No matter how any of us feels about the issue of abortion, we can all agree that no pregnant woman should ever be neglected or endangered by a careless abortion provider,” Holcroft said in his opening remarks.
The bill’s proponents, including the Department of Health and Human Services’ chief medical officer, Timothy Tesmer, M.D., told the committee medication abortions are widely used in Nebraska and that complications are difficult…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
